Sunshield Chemicals Limited reported its audited financial results for the quarter and year ended March 31, 2026, demonstrating significant growth in profitability. The company's net profit for the fourth quarter rose by 85.71% to ₹1,064 lakh, compared to ₹574 lakh in the corresponding period of the previous year. For the full fiscal year, the net profit more than doubled to ₹2,958 lakh from ₹1,457 lakh in the prior year. The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on May 13, 2026, with the statutory auditors issuing an unmodified opinion. The company also published an extract of these financial results as a newspaper advertisement in Financial Express (English) and Mumbai Lakshadeep (Marathi), in compliance with SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations.

Financial Performance

Revenue from operations for the quarter stood at ₹11,007 lakh, a slight decrease from ₹11,124 lakh in the same quarter last year. However, the annual revenue showed robust growth, increasing to ₹44,398 lakh for the year ended March 31, 2026, up from ₹36,894 lakh in the previous year. The profit before tax for the quarter was ₹1,411 lakh, while for the full year, it stood at ₹3,954 lakh, compared to ₹1,804 lakh in the prior year. The company's earnings per share (EPS) for the full year improved significantly to ₹37.15 from ₹19.61 in the previous year, while the quarterly EPS stood at ₹12.12. The following table summarises the key financial metrics across reporting periods:

Dividend and Corporate Actions

The Board of Directors has recommended a final dividend of ₹3 per equity share of the face value of ₹10 each for the financial year ended March 31, 2026. The total dividend payout amounts to ₹263.85 lakh and is subject to the approval of shareholders at the ensuing 39th Annual General Meeting. Additionally, the Board approved the reappointment of Mr. Cyrus Poonevala as an Independent Director for a second term of five years, effective from January 15, 2027, subject to shareholder approval. The company also completed a Rights Issue during the year, issuing 14,41,776 equity shares at a price of ₹901 per share, aggregating to ₹12,990.40 lakhs, with proceeds utilised for debt repayment and general corporate purposes.

Sunshield Chemicals Limited announced that its Board of Directors has approved the reappointment of Mr. Cyrus Poonevala as an Independent Director. The decision was taken during a Board meeting held on May 13, 2026, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. The reappointment is based on the recommendation of the company's Nomination and Remuneration Committee.

Mr. Poonevala has been reappointed for a second term of five years, effective from January 15, 2027, until January 14, 2032. This appointment is subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the company. Mr. Poonevala was initially appointed for a term ending on January 14, 2027.

Mr. Cyrus Poonevala is an experienced Aircraft Engineer with over 30 years of experience in the aviation industry, with a specific focus on maintenance. The company stated that his experience enables him to provide balanced guidance and contribute to the Board in matters relating to operations, risk oversight, and governance. He is not related to any of the existing Directors of the company and is not debarred from holding the office of Director by virtue of any SEBI order or any other authority.